Protein tyrosine phosphatases (PTPs) play vital roles in numerous cellular processes and are implicated in a growing number of human diseases, ranging from cancer to cardiovascular, immunological, infectious, neurological, and metabolic diseases. The Vaccinia H1-related (VHR) PTP is a dual-specific Erk and Jnk phosphatase, the loss of which causes specific cell cycle arrest in HeLa carcinoma cells, suggesting that VHR inhibition may be a useful approach to halt the growth of cancer cells without detrimental effects on normal cells. Recent studies by collaborators and us suggest that VHR is upregulated in several cervix cancer cell lines, in squamous intraepithelial lesions, and squamous cell carcinomas of the uterine cervix. This biochemical assay employs a colorimetric readout based on the enzyme's ability to liberate phosphate from p-nitrophenyl phosphate (pNPP) and its reaction with Biomol Green reagent. Chemical Library Screening.  A set of 50,000 drug-like molecules from the DIVERSet library (ChemBridge, Inc.) was screened in a 96-well format in vitro phosphatase assay.  Compounds had a working concentration of 0.15 mg/ml in 10% DMSO.  Each reaction contained 180 nM VHR, 4 mM pNPP, and 0.02 mg/mL compound in 0.1 M Bis-Tris pH 6.0 reaction buffer with 1 mM dithiothreitol (DTT) present.  The final volume amounted to 70 uL and contained 1.4% DMSO.  The reaction was initiated by addition of pNPP after a preincubation of the enzyme with compounds for 10 min at room temperature.  After 15 min, the reaction was quenched by addition of 140 uL BIOMOL GREEN Reagent, and the pNPP hydrolysis was determined by measuring the absorbance of the complexed free phosphate at 620 nm.  The nonenzymatic hydrolysis of the substrate was corrected by measuring the negative control without addition of enzyme.  Other controls included a positive control (no inhibitor added), a background control (no substrate added), and a control with 200 uM of the general PTP inhibitor sodium orthovanadate.  To quantitate the inhibitory efficacy of the library compounds, we determined the ratio of inhibition in comparison to the positive control.  Every compound with >=60% inhibition was cherry-picked and rescreened using the same assay format.  Compounds that showed >=60% inhibition also in the confirmatory screen were regarded as hit.  A total of 221 hits were identified in the confirmation screen.
bao:BAO_0001067 "1992_2" ; # "is primary assay of" -> "1992_2"
bao:BAO_0001067 "2004" ; # "is primary assay of" -> "2004"
bao:BAO_0001067 "2074" ; # "is primary assay of" -> "2074"
bao:BAO_0001067 "2082" ; # "is primary assay of" -> "2082"
bao:BAO_0001067 "2083" ; # "is primary assay of" -> "2083"
bao:BAO_0000812 "1661" ; # "has summary assay" -> "1661"
bao:BAO_0000808 bao:BAO_0000031 ; # "has primary assay" -> "primary assay"
bao:BAO_0000205 bao:BAO_0000217 ; # "has assay format" -> "biochemical format"
bao:BAO_0000205 bao:BAO_0000224 ; # "has assay format" -> "protein format"
bao:BAO_0000205 bao:BAO_0000357 ; # "has assay format" -> "single protein format"
bao:BAO_0000409 bao:BAO_0000410 ; # "assay measurement type" -> "endpoint assay"
bao:BAO_0002850 bao:BAO_0000534 ; # "has assay readout content" -> "single readout"
bao:BAO_0002851 "single parameter" ; # "has assay readout content parametricity" -> "single parameter"
bao:BA0_0090012 bao:BAO_0000295 ; # "has participant" -> "phosphatase" || bao:BAO_0003102 bao:BAO_00020144 ; # "has role" -> "target"
bao:BAO_0002855 bao:BAO_0002762 ; # "is bioassay type of" -> "phosphatase activity assay"
bao:BAO_0000212 bao:BAO_0000124 ; # "has assay method" -> "enzyme activity measurement method"
bao:BAO_0000212 bao:BAO_0000139 ; # "has assay method" -> "direct enzyme activity measurement method"
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> bao:BAO_0000484 ; # "has assay design method" -> "enzyme inhibition"
bao:BAO_0000207 bao:BAO_0000049 ; # "has detection method" -> "spectrophotometry method"
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> "Identification of small molecules that inhibit VHR1" ; # "screening campaign name" -> "Identification of small molecules that inhibit VHR1"
bao:BAO_0002853 "HTS Colorimetric assay for the identification of compounds that inhibit VHR1" ; # "has assay title" -> "HTS Colorimetric assay for the identification of compounds that inhibit VHR1"
bao:BAO_0002867 bao:BAO_0000513 ; # "has assay footprint" -> "96 well plate"
bao:BAO_0000109 "25 degree celsius" ; # "has temperature value" -> "25 degree celsius"
bao:BAO_0002833 "15 minute" ; # "has incubation time value" -> "15 minute"
bao:BA0_0090012 bao:BAO_0001018 ; # "has participant" -> "Sodium orthovanadate"
bao:BAO_0000740 bao:BAO_0000080 ; # "has assay control" -> "positive control"
bao:BA0_0090012 "no inhibitor" ; # "has participant" -> "no inhibitor"
bao:BAO_0000740 bao:BAO_0000079 ; # "has assay control" -> "negative control"
bao:BAO_0002857 "no enzyme" ; # "has signal direction" -> "no enzyme"
bao:BAO_0000740 bao:BAO_0000168 ; # "has assay control" -> "low signal control"
bao:BAO_0000740 "no substrate" ; # "has assay control" -> "no substrate"
bao:BAO_0000740 bao:BAO_0000334 ; # "has assay control" -> "background control"
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> "Lutz Tautz" ; # "material entity assay provider" -> "Lutz Tautz" || bao:BAO_0003102 bao:BAO_0000027 ; # "has role" -> "assay provider"
bao:BAO_0002020 bao:BAO_0000372 ; # "has assay phase characteristic" -> "homogeneous phase"
bao:BAO_0002000 bao:BAO_0001018 ; # "has measured entity" -> "Sodium orthovanadate" || bao:BAO_0003102 <http://purl.obolibrary.org/obo/CHEBI_35222> ; # "has role" -> "inhibitor"
bao:BA0_0090012 bao:BAO_0000895 ; # "has participant" -> "DTT" || bao:BAO_0003102 <http://purl.obolibrary.org/obo/CHEBI_63247> ; # "has role" -> "reducing agent"
bao:BA0_0090012 "\"Para-nitrophenyl phosphate, pNPP\"" ; # "has participant" -> ""Para-nitrophenyl phosphate, pNPP"" || bao:BAO_0003102 bao:BAO_00020143 ; # "has role" -> "substrate"
bao:BA0_0090012 "Dual specificity protein phosphatase 3" ; # "has participant" -> "Dual specificity protein phosphatase 3"
bao:BAO_0002921 <http://purl.obolibrary.org/obo/NCBITaxon_9606> ; # "has organism" -> "Homo sapiens"
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> "P51452" ; # "uniprot ID" -> "P51452"
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> "9606" ; # "NCBI taxonomy ID" -> "9606"
bao:BAO_0002662 bao:BAO_0002157 ; # "has quality" -> "native form"
bao:BAO_0002897 bao:BAO_0000360 ; # "has preparation method" -> "recombinant expression"
bao:BA0_0090012 "free phosphate" ; # "has participant" -> "free phosphate"
bao:BAO_0002000 bao:BAO_0002001 ; # "has measured entity" -> "measured entity"
bao:BAO_0002857 bao:BAO_0000261 ; # "has signal direction" -> "signal decrease corresponding to inhibition"
bao:BA0_0090012 bao:BAO_0000176 ; # "has participant" -> "small molecule" || bao:BAO_0003102 bao:BAO_00020137 ; # "has role" -> "perturbagen"
bao:BAO_0000212 bao:BAO_0000574 ; # "has assay method" -> "single perturbagen"
bao:BAO_0000648 bao:BAO_0000735 ; # "compound library" -> "DIVERSet"
bao:BAO_0000737 bao:BAO_0000720 ; # "has manufacturer" -> "ChemBridge" || bao:BAO_0003102 bao:BAO_0002627 ; # "has role" -> "compound library manufacturer"
bao:BAO_0002865 bao:BAO_0000700 ; # "uses detection instrument" -> "ELx808 Absorbance Microplate Reader"
bao:BAO_0000737 bao:BAO_0000861 ; # "has manufacturer" -> "Bio-Tek Instruments" || bao:BAO_0003102 bao:BAO_0002628 ; # "has role" -> "instrumentation manufacturer"
bao:BAO_0000568 "620 nanometer" ; # "absorbance wavelength" -> "620 nanometer"
bao:BAO_0000337 bao:BAO_0000201 ; # "has percent response" -> "percent inhibition"
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> "5" ; # "PubChem TID" -> "5"
bao:BAO_0000182 <http://purl.org/obo/owl/UO#UO_0000187> ; # "has response unit" -> "percent"
bao:BAO_0002666 "20" ; # "has concentration value" -> "20"
bao:BAO_0000183 <http://purl.org/obo/owl/UO#UO_0000064> ; # "has concentration unit" -> "micromolar"
bao:BAO_0002787 "1" ; # "has concentration-point number" -> "1"
bao:BAO_0000196 bao:BAO_0000091 ; # "has mode of action" -> "inhibition"
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> "kunie" ; # "Annotated by" -> "kunie"
bao:BAO_0000809 bao:BAO_0000030 ; # "has confirmatory assay" -> "confirmatory assay"
bao:BAO_0000208 bao:BAO_0000190 ; # "has endpoint" -> "IC50"
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> "2" ; # "PubChem TID" -> "2"
